501
Participants
Start Date
July 31, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Satavaptan
oral administration once daily
placebo
oral administration once daily
Sanofi-Aventis Administrative Office, Malvern
Sanofi-Aventis Administrative Office, San Isidro
Sanofi-Aventis Administrative Office, Macquarie Park
Sanofi-Aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, Sarajevo
Sanofi-Aventis Administrative Office, Sofia
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Zagreb
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Netanya
Sanofi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, Kuala Lumpur
Sanofi-Aventis Administrative Office, Porto Salvo
Sanofi-Aventis Administrative Office, Bucharest
Sanofi-Aventis Administrative Office, Belgrade
Sanofi-Aventis Administrative Office, Singapore
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Seoul
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Taipei
Sanofi-Aventis Administrative Office, Guildford Surrey
Lead Sponsor
Sanofi
INDUSTRY